Felix Gonzalez-Lopez de Turiso

4PUBLICATIONS
3CO-AUTHORS
Biologically active moleculesCellular nervous systemCheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 10, 2022
Selective TYK2 inhibitors as potential therapeutic agents: a patent review (2019-2021).

Felix Gonzalez Lopez de Turiso, Kevin Guckian

|Oct 15, 2021
Discovery of Potent, Selective, and Brain-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors that Modulate Brain Inflammation In Vivo.

J Howard Jones, Zhili Xin, Martin Himmelbauer

|May 04, 2021
Discovery of Potent and Brain-Penetrant Tau Tubulin Kinase 1 (TTBK1) Inhibitors that Lower Tau Phosphorylation In Vivo.

Tamara Halkina, Jaclyn L Henderson, Edward Y Lin

|Nov 12, 2019
Rational Design and Optimization of a Novel Class of Macrocyclic Apoptosis Signal-Regulating Kinase 1 Inhibitors.

Martin K Himmelbauer, Zhili Xin, J Howard Jones

Pageof 1

Frequent Collaborators

1 joint publications

Jaclyn L Henderson

1 joint publications

Martin K Himmelbauer

1 joint publications

Ru Wei